2019
The effect of contrast agents on left ventricular parameters calculated by a threshold-based software module: does it truly matter?
Szűcs A, Kiss A, Suhai F, Tóth A, Gregor Z, Horváth M, Czimbalmos C, Csécs I, Dohy Z, Szabó L, Merkely B, Vágó H. The effect of contrast agents on left ventricular parameters calculated by a threshold-based software module: does it truly matter? The International Journal Of Cardiovascular Imaging 2019, 35: 1683-1689. PMID: 31037474, PMCID: PMC6700040, DOI: 10.1007/s10554-019-01587-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomechanical PhenomenaCase-Control StudiesContrast MediaFemaleHeart VentriclesHumansImage Interpretation, Computer-AssistedIsolated Noncompaction of the Ventricular MyocardiumMagnetic Resonance Imaging, CineMaleMeglumineMiddle AgedOrganometallic CompoundsPredictive Value of TestsProspective StudiesReproducibility of ResultsSoftwareStroke VolumeVentricular Function, LeftYoung AdultConceptsSteady-state free precessionGadobenate dimeglumineCine imagesLeft ventricular parametersAdministration of contrast agentContrast agentsLeft ventricular volumeBlood-myocardium contrastEffects of contrast agentsNoncompaction cardiomyopathyVentricular parametersTrabecular musclesVentricular volumeCardiac parametersPre-CASShort axisTime-saving techniqueGadobutrolTrabecular massH groupFree precessionTrabecularEffect of CALVmassCardiomyopathy
2014
Advancing pharmacovigilance through academic–legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis—a research on adverse drug events and reports (RADAR) report
Edwards BJ, Laumann AE, Nardone B, Miller FH, Restaino J, Raisch DW, McKoy JM, Hammel JA, Bhatt K, Bauer K, Samaras AT, Fisher MJ, Bull C, Saddleton E, Belknap SM, Thomsen HS, Kanal E, Cowper SE, Abu Alfa AK, West DP. Advancing pharmacovigilance through academic–legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis—a research on adverse drug events and reports (RADAR) report. British Journal Of Radiology 2014, 87: 20140307. PMID: 25230161, PMCID: PMC4170864, DOI: 10.1259/bjr.20140307.Peer-Reviewed Original ResearchConceptsGadolinium-based contrast agentsAdverse drug eventsDrug eventsMedicines AgencyGadopentetate dimeglumineDrug Administration Adverse Event Reporting SystemAdverse Event Reporting SystemDanish Medicines AgencyNephrogenic systemic fibrosisEvent Reporting SystemEuropean Medicines AgencyNSF casesHistopathological dataContrast agentsSystemic fibrosisDrug AdministrationLegal data setsUnconfounded casesGadobenate dimeglumineMean numberDimeglumineReporting systemPharmacovigilance researchSafety informationPharmacovigilance
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply